Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay

Virology

Volumn 254, Issue 2, 1999, Pages 235-244

  Okuma, Kazu ^a   Nakamura, Minoru ^a   Nakano, Shuji ^a   Niho, Yoshiyuki ^a   Matsuura, Yoshiharu ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0033557076     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9530     Document Type: Article

References (56)

1. Agadjanyan, M. G., Ugen, K. E., Wang, B., Williams, W. V., and Weiner, D. B. (1994). Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection. J. Virol. 68, 485-493.
2. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., and Berger, E. A. (1996). CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
3. Arp, J., Levatte, M., Rowe, J., Perkins, S., King, E., Leystra-Iantz, C., Foung, S. K. H., and Dekaban, G. A. (1996). A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: Expression of gp46 by the vaccinia virus/T7 polymerase system. J. Virol. 70, 7349-7359.
4. Baba, E., Nakamura, M., Tanaka, Y., Kuroki, M., Itoyama, Y., Nakano, S., and Niho, Y. (1993). Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1(HTLV-1) identified by human monoclonal antibodies. J. Immunol. 151, 1013-1024.
5. Baba, E., Nakamura, M., Ohkuma, K., Kira, J.-I, Tanaka, Y., Nakano, S., and Niho, Y. (1995). A peptide-based human cell leukemia virus type I vaccine containing and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 154, 399-412.
6. D'Souza, M. P., and Harden, V. A. (1996). Chemokines and HIV-1 second receptors. Nat. Med. 2, 1293-1300.
7. Davanloo, P., Rosenberg, A. H., Dunn, J. J., and Studier, F. W. (1984). Cloning and expression of the gene for bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 81, 2035-2039.
8. Delamarre, L., Pique, C., Pham, D., Tursz, T., and Dokhélar, M.-C. (1994). Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J. Virol. 68, 3544-3549.
9. Delamarre, L., Rosenberg, A. R., Pique, C., Pham, D., and Dokhélar, M.-C. (1997). A novel human T-cell leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J. Virol. 71, 259-266.
10. Denesvre, C., Sonigo, P., Corbin, A., Ellerbrok, H., and Sitbon, M. (1995). Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J. Virol. 69, 4149-4157.
11. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
12. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
13. Fan, N., Gavalchin, J., Paul, B., Wells, K. H., Lane, M. J., and Poiesz, B. J. (1992). Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J. Virol. 30, 905-910.
14. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
15. Fukudome, K., Furuse, M., Imai, T., Nishimura, M., Takagi, S., Hinuma, Y., and Yoshie, O. (1992a). Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human-T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: Altered glycosylation of C33 antigen in HTLV-I-positive cells. J. Virol. 66, 1394-1401.
16. Fukudome, K., Furuse, M., Fukuhara, N., Orita, S., Imai, T., Takagi, S., Nagira, M., Hinuma, Y., and Yoshie, O. (1992b). Strong induction of ICAM-1 in human cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia- Derived cell lines. Int. J. Cancer 52, 418-427.
17. Furuse, M., Fukudome, K., Imai, T., Uwabe, K.-I., Hinuma, Y., and Yoshie, O. (1992). Induction of strong homotypic adhesion in human cell lines positive with human T-cell leukemia virus type 1 by monoclonal antibodies to MHC class I and β2-microglobulin. Cell. Immunol. 143, 298-309.
18. Gavalchin, J., Fan, N., Lane, M. J., Papsidero, L., and Poiesz, B. J. (1993). Identification of putative cellular receptor for HTLV-I by a monoclonal antibody, Mab34-23. Virology 194, 1-9.
19. Gavalchin, J., Fan, N., Waterbury P. G., Corbett, E., Faldasz, B. D., Peshick, S. M., Poiesz, B. J., and Lane, M. J. (1995). Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology 212, 196-203.
20. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A., and Thé, G. D. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-409.
21. Hildreth, J. E. K., Subramanium, A., and Hampton, R. A. (1997). Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: Evidence for involvement of cell adhesion molecules in HTLV-1 biology. J. Virol. 71, 1173-1180.
22. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K.-I., Shirakawa, S., and Miyoshi, I. (1981). Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad Sci. USA 78, 6476-6480.
23. Hoxie, J. A., Matthews, D. M., and Cines, D. B. (1984). Infection of human endothelial cells by human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 81, 7591-7595.
24. Ida, H., Kurata, A., Eguchi, K., Yamashita, I., Nakashima, M., Sakai, M., Kawabe, Y., Nakamura, T., and Nagataki, S. (1994). Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: Role of cell-to-cell contact. Antiviral Res. 23, 143-159.
25. Imai, T., Fukudome, K., Takagi, S., Nagira, M., Furuse, M., Fukuhara, N., Nishimura, M., Hinuma, Y., and Yoshie, O. (1992). C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol. 149, 2879-2886.
26. Imai, T., and Yoshie, O. (1993). C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the trans-membrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol. 151, 6470-6481.
27. Kannagi, M., Kuroda, M. J., Maeda, Y., and Harada, S. (1991). Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-I (HIV-I) on MOLT-4 cells. Microbiol. Immunol. 35, 729-740.
28. Krichbaum-Stenger, K., Poiesz, B. J., Keller, P., Ehrlich, G., Gavalchin, J., Davis, B. H., and Moore, J. L. (1987). Specific adsorption of HTLV-I to various target human and animal cells. Blood 70, 1303-1311.
29. Kuroki, M., Nakamura, M., Itoyama, Y., Tanaka, Y., Shiraki, H., Baba, E., Esaki, T., Tatsumoto, T., Nagafuchi, S., Nakano, S., and Niho, Y. (1992). Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. J. Immunol. 149, 940-948.
30. Landau, N. R., Page, K. A., and Littman, D. R. (1991). Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65, 162-169.
31. Li, Q., Camerini, D., Xie, Y., Greenwald, M., Kuritzkes, D. R., and Chen, I. S. Y. (1996). Syncytium formation by recombinant HTLV-II envelope glycoprotein. Virology 218, 279-284.
32. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., and Hinuma, Y. (1981). Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294, 770-771.
33. Mochizuki, M., Watanabe, T., Yamaguchi, K., Tajima, K., Yoshimura, K., Nakashima, S., Shirao, M., Araki, S., Miyata, N., Mori, S., and Takatsuki, K. (1992). Uveitis associated with human T lymphotropic virus type I: Seroepidemiologic, clinical, and virologic studies. J. Infect. Dis. 166, 943-944.
34. Nagy K., Clapham, P., Cheingsong-Popov, R., and Weiss, R. A. (1983). Human T-cell leukemia virus type I: Induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32, 321-328.
35. Niwa, H., Yamamura, K., and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-200.
36. Nussbaum, O., Broder, C. C., and Berger, E. A. (1994). Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68, 5411-5422.
37. Okuma, K., Nakamura, M., Nakano, S., Tanaka, Y., and Niho, Y. (in press). Identification of a novel bovine serum protein which is involved in human T-cell leukemia virus type I (HTLV-I)-induced syncytium formation. Arch. Virol.
38. Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara, M., and Igata, A. (1987). Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann. Neurol. 21, 117-122.
39. Palker, T. J., Riggs, E. R., Spragion, D. E., Muir, A. J., Scearce, R. M., Randall, R. R., McAdams, M. W., McKnight, A., Clapham, P. R., Weiss, R. A., and Haynes, B. F. (1992). Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J. Virol. 66, 5879-5889.
40. Pique, C., Tursz, T., and Dokhélar, M.-C. (1990). Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: A basis for envelope conservation? EMBO J. 9, 4243-4248.
41. Pique, C., Pham, D., Tursz, T., and Dokhélar, M.-C. (1992). Human T-cell leukemia virus type I envelope protein maturation process: Requirements for syncytium formation. J. Virol. 66, 906-913.
42. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77, 7415-7419.
43. Poon, B., and Chen, I. S. Y. (1998). Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication. J. Virol. 72, 1959-1966.
44. Ragheb, J. A., Yu, H., Hofmann, T., and Anderson, W. F. (1995). The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: Implications for the role of the ecotropic envelope and receptor in syncytium formation and viral entry. J. Virol. 69, 7205-7215.
45. Roos, D. S., Duchala, C. S., Stephensen, C. B., Holmes, K. V, and Choppin, P. W. (1990). Control of virus-induced cell fusion by host cell lipid composition. Virology 175, 345-357.
46. Rosenberg, A. R., Delamarre, L., Pique, C., Pham, D., and Dokhélar, M.-C. (1997). The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J. Virol. 71, 7180-7186.
47. Sagara, Y., Inoue, Y., Shiraki, H., Jinno, A., Hoshino, H., and Maeda, Y. (1996). Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. J. Virol. 70, 1564-1569.
48. Sagara, Y., Ishida, C., Inoue, Y., Shiraki, H., and Maeda, Y. (1997). Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. J. Virol. 71, 601-607.
49. Sagara, Y., Ishida, C., Inoue, Y., Shiraki, H., and Maeda, Y. (1998). 71-Kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J. Virol. 72, 535-541.
50. Seiki, M., Hattori, S., Hirayama, Y., and Yoshida, M. (1983). Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80, 3618-3622.
51. Shida, H., Tochikura, T., Sato, T., Konno, T., Hirayoshi, K., Seki, M., Ito, Y., Hatanaka, M., Hinuma, Y., Sugimto, M., Takahashi-Nishimaki, F., Maruyama, T., Miki, K., Suzuki, K., Morita, M., Sashiyama, H., and Hayami, M. (1987). Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J. 6, 3379-3384.
52. Siess, D. C., Kozak, S. L., and Kabat, D. (1996). Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J. Virol. 70, 3432-3439.
53. Sommerfeit, M. A., and Weiss, R. A. (1990). Receptor interference groups of 20 retroviruses plating on human cells. Virology 176, 58-69.
54. Sommerfelt, M. A., Williams, B. P., Clapham, P. R., Solomon, E., Goodfellow, P. N., and Weiss, R. A. (1988). Human T cell leukemia virus use a receptor determined by human chromosome 17. Science 242, 1557-1559.
55. Sutton, R. E., and Littman, D. R. (1996). Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70, 7322-7326.
56. Tanaka, Y., Tanaka, R., Terada, E., Koyanagi, Y., Miyano-Kurosaki, N., Yamamoto, N., Baba, E., Nakamura, M., and Shida, H. (1994). Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 68, 6323-6331.